12.33

3.75% -0.48

Cartesian Therapeutics Inc (RNAC)

Overview News Price History Option Chain Financials Discussions Forecast

Cartesian Therapeutics Inc stock is traded at $12.33, with a volume of 77,855. It is down -3.75% in the last 24 hours and up +13.22% over the past month. Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Previous Close:

$12.81

Open:

$12.56

24h Volume:

77,855

Relative Volume:

1.09

Market Cap:

$320.02M

Revenue:

$26.00M

Net Income/Loss:

$-219.71M

P/E Ratio:

-0.2476

EPS:

-49.8

Net Cash Flow:

$-51.37M

1W Performance:

-7.50%

1M Performance:

+13.22%

6M Performance:

-36.15%

1Y Performance:

-20.30%

1-Day Range:

$12.06

$13.10

1-Week Range:

$12.06

$14.56

52-Week Range:

$8.46

$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Name

Cartesian Therapeutics Inc

Sector

Healthcare (1164)

Industry

Biotechnology (649)

Phone

301-348-8698

Address

7495 NEW HORIZON WAY, FREDERICK

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

RNAC's Discussions on Twitter

Compare RNAC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RNAC Cartesian Therapeutics Inc	12.33	332.47M	26.00M	-219.71M	-51.37M	-49.80
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	673.80	41.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-25	Initiated	Wedbush	Outperform
Dec-19-24	Initiated	BTIG Research	Buy
Aug-06-24	Initiated	TD Cowen	Buy
Jul-02-24	Downgrade	Oppenheimer	Outperform → Perform
Jun-04-24	Initiated	Oppenheimer	Outperform
May-24-24	Initiated	Mizuho	Buy
Apr-23-24	Reiterated	H.C. Wainwright	Buy
Apr-23-24	Initiated	Leerink Partners	Outperform
Aug-18-23	Downgrade	SVB Securities	Outperform → Market Perform
Jun-14-22	Reiterated	Needham	Buy
Jun-06-22	Initiated	SVB Leerink	Outperform
Jun-15-21	Initiated	BTIG Research	Buy
Jan-26-21	Upgrade	Mizuho	Neutral → Buy
Oct-01-20	Downgrade	Mizuho	Buy → Neutral
Oct-01-20	Downgrade	William Blair	Outperform → Mkt Perform
Jun-12-20	Downgrade	Stifel	Buy → Hold
Apr-28-20	Initiated	H.C. Wainwright	Buy
Jan-29-20	Initiated	Cantor Fitzgerald	Overweight
Jan-21-20	Initiated	William Blair	Outperform
Jun-27-18	Initiated	Janney	Buy
Mar-30-17	Reiterated	UBS	Buy

View All

Cartesian Therapeutics Inc Stock (RNAC) Latest News

02:58 AM

Can momentum traders help lift Cartesian Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser

02:58 AM

Aug 01, 2025

What are the technical indicators suggesting about Cartesian Therapeutics Inc.Free Stock Forecasts For 2025 - jammulinksnews.com

Aug 01, 2025

Chart overlay techniques for tracking Cartesian Therapeutics Inc.Free Alert Feed for Momentum Based Picks - Newser

Aug 01, 2025

How to integrate Cartesian Therapeutics Inc. into portfolio analysis toolsRisk-Managed Trade Alerts for Consistency - Newser

Aug 01, 2025

Jul 31, 2025

Price action breakdown for Cartesian Therapeutics Inc.Free Fast Entry High Potential Stock Alerts - Newser

Jul 31, 2025

How many analysts rate Cartesian Therapeutics Inc. as a “Buy”Free Stock Target Finder With Proven Results - jammulinksnews.com

Jul 31, 2025

What makes Cartesian Therapeutics Inc. stock price move sharplyWeekly Price Target Forecast and Alerts - Newser

Jul 31, 2025

Technical signs of recovery in Cartesian Therapeutics Inc.Fast Return Equity Forecast With Logic - Newser

Jul 31, 2025

Jul 30, 2025

How Cartesian Therapeutics Inc. stock performs during market volatilityFree Optimized Watchlist With Daily Adjustments - Newser

Jul 30, 2025

Myasthenia Gravis Market Growth to Accelerate in Forecast - openPR.com

Jul 30, 2025

Cartesian Therapeutics Inc. Moves Into Overbought Range Analysts CautiousBuy Alerts With Low Risk Confirmation Noted - metal.it

Jul 30, 2025

Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionAlpha Stock Picks with Chart Confirmation - Newser

Jul 30, 2025

How to use a screener to detect Cartesian Therapeutics Inc. breakoutsPortfolio Building Plan and Summary Guide - Newser

Jul 30, 2025

New Product Launches: Will They Boost Cartesian Therapeutics Inc. Stock in 2025Entry and Exit Strategy Optimizer Tool Tested - metal.it

Jul 30, 2025

Jul 29, 2025

Risk vs reward if holding onto Cartesian Therapeutics Inc.Free Momentum Based Equity Trading Plan - Newser

Jul 29, 2025

Screener Results Flag Cartesian Therapeutics Inc. as OversoldSecure Return Focused Investment Plan Released - metal.it

Jul 29, 2025

Jul 28, 2025

How strong is Cartesian Therapeutics Inc. company’s balance sheetSmart Portfolio Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025

Published on: 2025-07-28 21:34:06 - beatles.ru

Jul 28, 2025

Cartesian Therapeutics Inc.’s Price Action Aligns with Quant SignalsLow Risk Equity Screener With Results Shared - metal.it

Jul 28, 2025

How does Cartesian Therapeutics Inc. generate profit in a changing economySuperior portfolio returns - jammulinksnews.com

Jul 28, 2025

How to integrate Cartesian Therapeutics Inc. into portfolio analysis tools Swing Trade Picks with High Potential - Newser

Jul 28, 2025

What are Cartesian Therapeutics Inc. company’s key revenue driversMaximize your gains with professional insights - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Is Cartesian Therapeutics Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com

Jul 27, 2025

What is the risk reward ratio of investing in Cartesian Therapeutics Inc. stockInvest confidently with data-driven strategies - jammulinksnews.com

Jul 27, 2025

How Interest Rate Changes Impact Cartesian Therapeutics Inc. Stock PerformanceControlled Risk High Reward Plan - Newser

Jul 27, 2025

Jul 26, 2025

What analysts say about Cartesian Therapeutics Inc. stockBreakout portfolio performance - jammulinksnews.com

Jul 26, 2025

Jul 25, 2025